Cited by 12Cancer survivorship and careHealth Policy Implementation ScienceWomen's cancer prevention and management

Moving the Translational Needle in Breast Cancer Survivorship: Connecting Intervention Research to Clinical Practice

Open access
Brauer, Eden R., Ganz, Patricia A.·2022·Journal of Clinical Oncology

Abstract

Breast cancer is the most common cancer in women worldwide, and advances in its early detection and treatment have yielded large and growing numbers of long-term survivors. 1Since 1989, the death rate for breast cancer has been in decline, and the 5-year and 10-year survival rates for invasive breast cancer have now reached 90% and 84%, respectively. 2Breast cancer has also been one of the most studied cancers with respect to both observational and intervention research, dating back to some of the earliest psychosocial research 50 years ago, first describing the impact of radical mastectomy. 3As a result, there is a large body of published literature that focuses on interventions for the physical and psychosocial outcomes after a breast cancer diagnosis, including pain, fatigue, neuropathy, body image, sexual dysfunction, cognitive impairment, and others.The focus of intervention research has also evolved over time with broader trends in health care delivery, and contemporary topics, such as financial toxicity, have only recently emerged.Many of these studies have also contributed to our understanding of biologic and behavioral mechanisms underlying long-term and late effects in cancer survivors.Importantly, these research advancements are a testament to the accessibility and willingness of survivors of breast cancer to participate in research that might help them or others.Through this historical lens, we consider the findings of the article accompanying this editorial, 4 in which the authors conducted a data synthesis that mapped systematic reviews of interventions for breast cancer survivors onto a contemporary survivorship framework. 5The overall aim of this analysis was to identify key gaps in the intervention research literature and examine the level of connectivity among the framework content elements.Published in 2019, the Cancer Survivorship Care Quality framework consists of five distinct, but inter-related domains of cancer survivorship care (physical effects, psychosocial effects, recurrences and new cancers, health promotion, and chronic conditions), surrounded by four contextual health care delivery domains (clinical structure, communication/decision making, care coordination, and patient/caregiver experience), which are then linked to four health care outcomes (health-related quality of life, emergency services/hospitalizations, costs, and mortality; Fig 1). 5 As one of the few comprehensive frameworks in the field, it provides a useful roadmap and common terminology to guide improvements in cancer survivorship care delivery, research, and policy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.22.00174

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Brauer, E. R., & Ganz, P. A.
Affiliations
University of California, Los Angeles (US)
Venue
Journal of Clinical Oncology
Published
2022-07-01
Volume
40
Issue
19
Pages
2069-2073
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W4224210016
Cited by
12
References
25
Citations by year
2026: 2 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 2
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Breast Cancer Research Foundation
  • National Cancer Institute (K08CA252615)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
breast cancer survivorship, survivorship care, intervention research, research-to-practice translation, psychosocial outcomes, late effects of cancer treatment, financial toxicity, health care delivery, research gaps
MeSH terms
Cancer Survivors, Survivorship, Breast, Breast Neoplasms, Female, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review